Oscar Health OSCR Non-current Restricted Cash and Cash Equivalents
Non-current Restricted Cash and Cash Equivalents at other companies
Other financials
Where this comes from
Reported directly by Oscar Health in its filing.
Tagged under the XBRL concept us-gaap:RestrictedCashAndInvestmentsNoncurrent.
The official record: Oscar Health’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Oscar Health's non-current restricted cash and cash equivalents.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Oscar Health's non-current restricted cash and cash equivalents?
- Oscar Health (OSCR) reported non-current restricted cash and cash equivalents of $28.63M in Q1 2026.
- How has Oscar Health's non-current restricted cash and cash equivalents changed year-over-year?
- Oscar Health's non-current restricted cash and cash equivalents decreased by 7.7% year-over-year, from $31.01M to $28.63M.
- What is the long-term trend for Oscar Health's non-current restricted cash and cash equivalents?
- Over 5 years (2020 to 2025), Oscar Health's non-current restricted cash and cash equivalents has grown at a 4.5% compound annual growth rate (CAGR), from $26.48M to $32.95M.
- What does non-current restricted cash and cash equivalents mean?
- This represents cash and cash equivalents that are legally or contractually restricted for specific purposes and are not available for general corporate use for a period exceeding one year. It often relates to regulatory requirements or collateral for long-term obligations.